<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">The trials, which will first be carried out among health workers, will be initially conducted in high-risk zones identified by the Arogya Setu application. It is reported that over 50 lakh people from cities including Delhi, Mumbai, Ahmedabad and Pune will be a part of the clinical trial. The Ayush ministry is also studying the impacts of Ayush-based prophylactic interventions in some preventive cases. In the first phase, patients are likely to be administered ashwagandha, and later the other drugs will be given to patients, depending on how they react or the severity of the symptoms (Times of 
 <ext-link ext-link-type="uri" xlink:href="http://india.com" xmlns:xlink="http://www.w3.org/1999/xlink">India.com</ext-link> 12 May 2020).
</p>
